Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response

Translational Research

Volumn 156, Issue 4, 2010, Pages 207-215

  Welsh, Kerry J ^a,b   Hwang, Shen An ^a   Hunter, Robert L ^a   Kruzel, Marian L ^a   Actor, Jeffrey K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORD FACTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTOFERRIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOMA; HISTOLOGY; IMMUNE RESPONSE; INFLAMMATION; LUNG TUBERCULOSIS; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGY; LUNG; LUNG DISEASE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PROTEIN SYNTHESIS; TOXICITY;

ANIMALS; CORD FACTORS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOMA; INTERLEUKIN-10; LACTOFERRIN; LUNG; LUNG DISEASES; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PROTEIN BIOSYNTHESIS; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS;

EID: 77957303723     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.06.001     Document Type: Article

References (54)

1. WHO WHO report 2009. Global tuberculosis control. Epidemiology, strategy, financing 2009 World Health Organization Geneva, Switzerland
2. S.H. Gillespie, and N. Kennedy Fluoroquinolones: a new treatment for tuberculosis? Int J Tuberc Lung Dis 2 1998 265 271 (Pubitemid 28168302)
3. D.G. Russell, P.J. Cardona, M.J. Kim, S. Allain, and F. Altare Foamy macrophages and the progression of the human tuberculosis granuloma Nat Immunol 10 2009 943 948
4. G.J. Churchyard, G. Kaplan, D. Fallows, R.S. Wallis, P. Onyebujoh, and G.A. Rook Advances in immunotherapy for tuberculosis treatment Clin Chest Med 30 2009 769 782
5. L.G. Wayne, and C.D. Sohaskey Nonreplicating persistence of mycobacterium tuberculosis Annu Rev Microbiol 55 2001 139 163
6. R.L. Hunter, L. Armitige, C. Jagannath, and J.K. Actor TB research at UT-Houston - a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis Tuberculosis 89 2009 S18 S25
7. J.K. Actor, S.A. Hwang, and M.L. Kruzel Lactoferrin as a natural immune modulator Curr Pharm Des 15 2009 1956 1973
8. H.S. Birgens The interaction of lactoferrin with human monocytes Dan Med Bull 38 1991 244 252
9. M.L. Hammarstrom, L. Mincheva-Nilsson, and S. Hammarstrom Functional lactoferrin receptors on activated human lymphocytes Adv Exp Med Biol 371A 1995 47 53
10. S. Iyer, T.T. Yip, T.W. Hutchens, and B. Lonnerdal Lactoferrin-receptor interaction. Effect of surface exposed histidine residues Adv Exp Med Biol 357 1994 245 252
11. J.K. Actor, S.A. Hwang, M. Olsen, M. Zimecki, R.L. Hunter, and M.L. Kruzel Lactoferrin immunomodulation of DTH response in mice Int Immunopharmacol 2 2002 475 486 (Pubitemid 34169743)
12. E. Damiens, J. Mazurier, and I. el Yazidi Effects of lactoferrin on NK cell cytotoxicity again haematopoietic and epithelial tumour cells Biochim Biophys Acta 1402 1998 277 287 (Pubitemid 28206922)
13. D. Legrand, E. Elass, M. Carpentier, and J. Mazurier Lactoferrin: a modulator of immune and inflammatory responses Cell Mol Life Sci 62 2005 2549 2559 (Pubitemid 41722207)
14. H. Shau, A. Kim, and S.H. Golub Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin J Leukoc Biol 51 1992 343 349
15. M. Zimecki, J. Mazurier, G. Spik, and J.A. Kapp Human lactoferrin induces phenotypic and functional changes in murine splenic B cells Immunology 86 1995 122 127
16. K. Sorimachi, K. Akimoto, Y. Hattori, T. Ieiri, and A. Niwa Activation of macrophages by lactoferrin: secretion of TNF-alpha, IL-8 and NO Biochem Mol Biol Int 43 1997 79 87 (Pubitemid 28297194)
17. K.M. Wilk, S.A. Hwang, and J.K. Actor Lactoferrin modulation of antigen-presenting-cell response to BCG infection Postepy Hig Med Dosw 61 2007 277 282
18. M.L. Kruzel, J.K. Actor, I. Boldogh, and M. Zimecki Lactoferrin in health and disease Postepy Hig Med Dosw 61 2007 261 267
19. S.A. Hwang, K.M. Wilk, Y.A. Bangale, M.L. Kruzel, and J.K. Actor Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes Med Microbiol Immunol 196 2007 171 180
20. M.L. Kruzel, Y. Harari, C.Y. Chen, and G.A. Castro Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice Inflammation 24 2000 33 44 (Pubitemid 30105938)
21. S.A. Hwang, K. Wilk, M.L. Kruzel, and J.K. Actor A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice Vaccine 27 2009 3026 3034
22. R.L. Hunter, M.R. Olsen, C. Jagannath, and J.K. Actor Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease Ann Clin Lab Sci 36 2006 371 386 (Pubitemid 44786684)
23. R.L. Hunter, M. Olsen, C. Jagannath, and J.K. Actor Trehalose 6,6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice Am J Pathol 168 2006 1249 1261
24. A.N. Abbott, T.V. Guidry, and K.J. Welsh 11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6'-dimycolate Neuroimmunomodulation 16 2009 147 154
25. K.J. Welsh, A.N. Abbott, and S.A. Hwang A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response Microbiology 154 2008 1813 1824
26. A. Bekierkunst, and E. Yarkoni Granulomatous hypersensitivity to trehalose-6,6'-dimycolate (cord factor) in mice infected with BCG Infect Immun 7 1973 631 638
27. R.L. Perez, J. Roman, and S. Roser Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6'-dimycolate J Interferon Cytokine Res 20 2000 795 804
28. H. Yamagami, T. Matsumoto, and N. Fujiwara Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice Infect Immun 69 2001 810 815 (Pubitemid 32109543)
29. T.V. Guidry, R.L. Hunter Jr., and J.K. Actor Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes Microbiology 153 2007 3360 3369
30. S.A. Hwang, and J.K. Actor Lactoferrin modulation of BCG-infected dendritic cell functions Int Immunol 21 2009 1185 1197
31. S.A. Hwang, M.L. Kruzel, and J.K. Actor Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages Biochimie 91 2009 76 85
32. C. Kan-Sutton, C. Jagannath, and R.L. Hunter Jr. Trehalose 6,6'-dimycolate on the surface of Mycobacterium tuberculosis modulates surface marker expression for antigen presentation and costimulation in murine macrophages Microbes Infect 11 2009 40 48
33. J. Indrigo, R.L. Hunter Jr., and J.K. Actor Influence of trehalose 6,6'-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages Microbiology 148 2002 1991 1998 (Pubitemid 34785283)
34. H.M. Algood, P.L. Lin, and J.L. Flynn Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis Clin Infect Dis 41 2005 S189 S193
35. H. Kaneko, H. Yamada, and S. Mizuno Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice Lab Invest 79 1999 379 386 (Pubitemid 29190427)
36. V. Kindler, A.P. Sappino, G.E. Grau, P.F. Piguet, and P. Vassalli The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection Cell 56 1989 731 740 (Pubitemid 19082507)
37. E. Roy, D.B. Lowrie, and S.R. Jolles Current strategies in TB immunotherapy Curr Mol Med 7 2007 373 386 (Pubitemid 46979701)
38. C. Paige, and W.R. Bishai Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view Cell Microbiol 12 2010 301 309
39. R.S. Wallis, P. Kyambadde, and J.L. Johnson A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis AIDS 18 2004 257 264 (Pubitemid 38253448)
40. H. Mayanja-Kizza, E. Jones-Lopez, and A. Okwera Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda J Infect Dis 191 2005 856 865 (Pubitemid 40349799)
41. P. Manzoni, M. Rinaldi, and S. Cattani Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial JAMA 302 2009 1421 1428
42. S. Tamano, K. Sekine, M. Takase, K. Yamauchi, M. Iigo, and H. Tsuda Lack of chronic oral toxicity of chemopreventive bovine lactoferrin in F344/DuCrj rats Asian Pac J Cancer Prev 9 2008 313 316
43. H. Ueno, T. Sato, and S. Yamamoto Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C Cancer Sci 97 2006 1105 1110 (Pubitemid 44322561)
44. P. Manzoni, L. Decembrino, and I. Stolfi Lactoferrin and prevention of late-onset sepsis in the preterm neonate in the NICU Early Hum Dev. 2010 Suppl 1:59-61.
45. M.O. Li, and R.A. Flavell Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10 Immunity 28 2008 468 476
46. D.O. Co, L.H. Hogan, S.I. Kim, and M. Sandor Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship Clin Immunol 113 2004 130 136 (Pubitemid 39296843)
47. E. Jouanguy, F. Altare, and S. Lamhamedi Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection N Engl J Med 335 1996 1956 1961 (Pubitemid 26428220)
48. J. Chan, and J. Flynn The immunological aspects of latency in tuberculosis Clin Immunol 110 2004 2 12 (Pubitemid 38177416)
49. M. Gonzalez-Juarrero, J.M. Hattle, and A. Izzo Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection J Leukoc Biol 77 2005 914 922 (Pubitemid 40770843)
50. J. Togawa, H. Nagase, and K. Tanaka Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance Am J Physiol Gastrointest Liver Physiol 283 2002 G187 G195 (Pubitemid 34666177)
51. M.L. Kruzel, Y. Harari, C.Y. Chen, and G.A. Castro The gut. A key metabolic organ protected by lactoferrin during experimental systemic inflammation in mice Adv Exp Med Biol 443 1998 167 173 (Pubitemid 28432183)
52. M. Kocieba, M. Zimecki, M. Kruzel, and J. Actor The adjuvant activity of lactoferrin in the generation of DTH to ovalbumin can be inhibited by bovine serum albumin bearing alpha-D-mannopyranosyl residues Cell Mol Biol Lett 7 2002 1131 1136 (Pubitemid 36119545)
53. M. Zimecki, and M.L. Kruzel Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice Immunol Lett 74 2000 183 188
54. E. Ishikawa, T. Ishikawa, and Y.S. Morita Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle J Exp Med 206 2009 2879 2888